No Data
No Data
No Data
No Data
No Data
Where NeoGenomics Stands With Analysts
Ratings for NeoGenomics (NASDAQ:NEO) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.In the table below, you'll find a summary of their recen
Benzinga02:00
NeoGenomics Is Maintained at Buy by Needham
NeoGenomics Is Maintained at Buy by Needham
Dow Jones01:27
NeoGenomics Price Target Cut to $19.00/Share From $24.00 by Needham
NeoGenomics Price Target Cut to $19.00/Share From $24.00 by Needham
Dow Jones01:27
Needham: Maintaining the NeoGenomics (NEO.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $24.00 to $19.00.
Needham: Maintaining the NeoGenomics (NEO.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $24.00 to $19.00.
Zhitong Finance01:21
NeoGenomics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 23.38% Needham $24 → $19 Maintains Buy 02/26/2024 29.87% Piper Sandler $18 → $20 Maintains Over
Benzinga01:16
CORRECTION: NeoGenomics Ticker Is NEO
CORRECTION: NeoGenomics Ticker Is NEO
Benzinga00:31
No Data
No Data